Youguo Chen

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Endometrial Cancer

Signaling Pathway

Induced Pluripotent Stem Cells

Top Venues

Molecular and cellular biochemistry

Recent patents on anti-cancer drug discovery

Current molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Lu Miao, Buze Chen, Li Jing, Tian Zeng, Youguo Chen
TPD52 as a Potential Prognostic Biomarker and its Correlation with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma: Bioinformatic Analysis and Experimental Verification. Recent patents on anti-cancer drug discovery (2024)
Lu Miao, Li Jing, Buze Chen, Tian Zeng, Youguo Chen
TPD52 is a Potential Prognostic Biomarker and Correlated with Immune Infiltration: A Pan-cancer Analysis. Current molecular medicine (2023)
Yan Zhu, Lijuan Yang, Youguo Chen
Retraction Note: Anhuienoside C inhibits human ovarian cancer cell growth by inducing apoptosis, suppression of cell migration and invasion, and targeting PI3K/AKT/mTOR signaling pathway. Molecular and cellular biochemistry (2023)
Yan Zhu, Lijuan Yang, Youguo Chen
Anhuienoside C inhibits human ovarian cancer cell growth by inducing apoptosis, suppression of cell migration and invasion, and targeting PI3K/AKT/mTOR signaling pathway. Molecular and cellular biochemistry 477 (7) (2022)